Vascular function of the peripheral circulation in patients with nephrosis

Kannel, 1984, The prognostic significance of proteinuria: The Framingham study, Am Heart J, 108, 1347, 10.1016/0002-8703(84)90763-4 Cameron, 1998, The nephrotic syndrome: Management, complications, and pathophysiology, 461 Ordonez, 1993, The increased risk of coronary heart disease associated with nephrotic syndrome, Kidney Int, 44, 638, 10.1038/ki.1993.292 Keane, 1992, Is the aggressive management of hyperlipidemia in nephrotic syndrome mandatory?, Kidney Int, 42, S134 Kaysen, 1999, New insights into lipid metabolism in the nephrotic syndrome, Kidney Int, 56, S18, 10.1046/j.1523-1755.1999.07105.x Gordon, 1999, Epidemiology of lipoproteins, 587 Phillips, 1989, Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes, Lancet, 2, 1434, 10.1016/S0140-6736(89)92042-4 Kannel, 1987, Fibrinogen and risk of cardiovascular disease: The Framingham Study, JAMA, 258, 1183, 10.1001/jama.1987.03400090067035 Moncada, 1991, Nitric oxide: physiology, pathophysiology, and pharmacology, Pharmacol Rev, 43, 109 Rubanyi, 1993, The role of endothelium in cardiovascular homeostasis and diseases, J Cardiovasc Pharmacol, 22, S1, 10.1097/00005344-199322004-00002 Sorensen, 1995, Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility, Br Heart J, 74, 247, 10.1136/hrt.74.3.247 Playford, 1998, Special article: Non-invasive measurement of endothelial function, Clin Exp Pharmacol Physiol, 25, 640, 10.1111/j.1440-1681.1998.tb02269.x Anderson, 1995, Close relation of endothelial function in the human coronary and peripheral circulations, J Am Coll Cardiol, 26, 1235, 10.1016/0735-1097(95)00327-4 Suwaidi, 2000, Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction, Circulation, 101, 948, 10.1161/01.CIR.101.9.948 Neunteufl, 2000, Late prognostic value of flow-mediated dilation in the brachial artery of patients with chest pain, Am J Cardiol, 86, 207, 10.1016/S0002-9149(00)00857-2 Celermajer, 1994, Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction, J Am Coll Cardiol, 24, 1468, 10.1016/0735-1097(94)90141-4 Vogel, 1998, Cholesterol, cholesterol lowering, and endothelial function, Prog Cardiovasc Dis, 41, 117, 10.1016/S0033-0620(98)80008-X Sax, 1987, Impaired forearm vasodilator reserve in patients with microvascular angina: Evidence of a generalized disorder of vascular function?, N Engl J Med, 317, 1366, 10.1056/NEJM198711263172202 Stroes, 1995, Impaired endothelial function in patients with nephrotic range proteinuria, Kidney Int, 48, 544, 10.1038/ki.1995.325 O'Neal, 1998, A comparison of LDL size determination using gradient gel electrophoresis and light-scattering methods, J Lipid Res, 39, 2086, 10.1016/S0022-2275(20)32507-4 Watts, 2000, Effects of diet and serotonergic agonist on hepatic apolipoprotein B-100 secretion and endothelial function in obese men, Q J Med, 93, 153, 10.1093/qjmed/93.3.153 Bradley, 1988, Abnormalities of the peripheral circulation in patients with chronic renal failure, Nephrol Dial Transplant, 3, 412, 10.1093/oxfordjournals.ndt.a091689 Kari, 1997, Physiology and biochemistry of endothelial function in children with chronic renal failure, Kidney Int, 52, 468, 10.1038/ki.1997.354 Pannier, 2000, Postischemic vasodilation, endothelial activation, and cardiovascular remodeling in end-stage renal disease, Kidney Int, 57, 1091, 10.1046/j.1523-1755.2000.00936.x Joannides, 1995, Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo, Circulation, 91, 1314, 10.1161/01.CIR.91.5.1314 Tagawa, 1994, Role of nitric oxide in reactive hyperemia in human forearm vessels, Circulation, 90, 2285, 10.1161/01.CIR.90.5.2285 Meredith, 1996, Postischemic vasodilation in human forearm is dependent on endothelium-derived nitric oxide, Am J Physiol, 270, H1435 Flavahan, 1992, Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity, Circulation, 85, 1927, 10.1161/01.CIR.85.5.1927 Liao, 1995, Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase, J Biol Chem, 270, 319, 10.1074/jbc.270.1.319 Pritchard, 1995, Native low-density lipoprotein increases endothelial cell nitric oxide synthase generation of superoxide anion, Circ Res, 77, 510, 10.1161/01.RES.77.3.510 Boger, 1998, Asymmetric dimethylarginine (ADMA): A novel risk factor for endothelial dysfunction: Its role in hypercholesterolemia, Circulation, 98, 1842, 10.1161/01.CIR.98.18.1842 Casino, 1994, Investigation of decreased availability of nitric oxide precursor as the mechanism responsible for impaired endothelium-dependent vasodilation in hypercholesterolemic patients, J Am Coll Cardiol, 23, 844, 10.1016/0735-1097(94)90628-9 Kugiyama, 1998, Association of remnant lipoprotein levels with impairment of endothelium-dependent vasomotor function in human coronary arteries, Circulation, 97, 2519, 10.1161/01.CIR.97.25.2519 Sorensen, 1994, Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level, J Clin Invest, 93, 50, 10.1172/JCI116983 O'Brien, 1997, Low-density lipoprotein size, high-density lipoprotein concentration, and endothelial dysfunction in non-insulin-dependent diabetes, Diabet Med, 14, 974, 10.1002/(SICI)1096-9136(199711)14:11<974::AID-DIA495>3.0.CO;2-I Zeiher, 1994, Coronary atherosclerotic wall thickening and vascular reactivity in humans: Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis, Circulation, 89, 2525, 10.1161/01.CIR.89.6.2525 Stamler, 1992, Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin, Proc Natl Acad Sci USA, 89, 7674, 10.1073/pnas.89.16.7674 Minamiyama, 1996, Albumin is an important vascular tonus regulator as a reservoir of nitric oxide, Biochem Biophys Res Commun, 225, 112, 10.1006/bbrc.1996.1138 Vehkavaara, 1999, In vivo endothelial dysfunction characterizes patients with impaired fasting glucose, Diabetes Care, 22, 2055, 10.2337/diacare.22.12.2055 Steinberg, 1996, Obesity/insulin resistance is associated with endothelial dysfunction: Implications for the syndrome of insulin resistance, J Clin Invest, 97, 2601, 10.1172/JCI118709 Woo, 1997, Hyperhomocyst(e)inemia is a risk factor for arterial endothelial dysfunction in humans, Circulation, 96, 2542, 10.1161/01.CIR.96.8.2542 Vallance, 1992, Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure, Lancet, 339, 572, 10.1016/0140-6736(92)90865-Z Bostom, 1995, Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case-control study, Atherosclerosis, 114, 93, 10.1016/0021-9150(94)05470-4 Hecker, 1993, Vasoconstriction and increased flow: Two principal mechanisms of shear stress-dependent endothelial autacoid release, Am J Physiol, 265, H828 Geers, 1984, Plasma and blood volumes in patients with the nephrotic syndrome, Nephron, 38, 170, 10.1159/000183302 Lewis, 1999, Endothelium-dependent relaxation by acetylcholine is impaired in hypertriglyceridemic humans with normal levels of plasma LDL cholesterol, J Am Coll Cardiol, 33, 805, 10.1016/S0735-1097(98)00667-6 Cockcroft, 1994, Preserved endothelium-dependent vasodilatation in patients with essential hypertension, N Engl J Med, 330, 1036, 10.1056/NEJM199404143301502